Target Name: Histocompatibility antigen-related
NCBI ID: G554223
Review Report on Histocompatibility antigen-related Target / Biomarker Content of Review Report on Histocompatibility antigen-related Target / Biomarker
Histocompatibility antigen-related
Other Name(s): LOC554223 | LOC554223 protein

LOC554223: A Promising Drug Target for Immune Response and Inflammation

Histocompatibility antigen-related (LOC554223) is a protein that is expressed in many different tissues and cells in the human body. It is a member of the histocompatibility antigen (HCA) family, which is a group of proteins that are involved in the immune response. HCA proteins play a crucial role in ensuring that the immune system does not attack the body's own tissues.

LOC554223 is a specific HCA protein that is expressed in the human spleen, liver, and kidney. It is also expressed in various other tissues and cells, including the heart, blood vessels, and the nervous system. LOC554223 is involved in the immune response by helping to regulate the movement of immune cells into the body's tissues.

One of the key functions of LOC554223 is its role in the regulation of T cells. T cells are a type of immune cell that play a crucial role in the immune response by recognizing and responding to foreign substances in the body. LOC554223 helps to ensure that T cells are able to migrate into the body's tissues and engage with potential enemies.

Another important function of LOC554223 is its role in the regulation of inflammation. When the body is exposed to a foreign substance, LOC554223 helps to regulate the release of inflammatory molecules. This helps to protect the body's tissues from damage and inflammation.

LOC554223 is also involved in the regulation of cell death. When the body is exposed to a foreign substance or when it is no longer needed, LOC554223 helps to regulate the death of cells. This helps to remove dead cells and prevent the formation of harmful aggregates that could cause disease.

In addition to its role in regulating the immune response and inflammation, LOC554223 is also involved in the regulation of the blood supply. When the body is injured or damaged, LOC554223 helps to regulate the movement of blood vessels into the affected area. This helps to deliver oxygen and nutrients to the damaged tissue and prevent the formation of blood clots.

LOC554223 is a unique protein that is expressed in many different tissues and cells in the body. Its role in the immune response, inflammation, and cell death makes it an attractive drug target. Studies have shown that LOC554223 can be effectively targeted by small molecules, making it a promising target for future drug development.

In conclusion, LOC554223 is a protein that is involved in the immune response, inflammation, and cell death. Its role in these processes makes it an attractive drug target, and its expression in many different tissues and cells in the body makes it a promising target for future drug development. Further research is needed to fully understand the role of LOC554223 in the immune response and to identify potential drug targets.

Protein Name: Histocompatibility Antigen-related

The "Histocompatibility antigen-related Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Histocompatibility antigen-related comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Histone | Histone acetyltransferase (HAT) | Histone deacetylase | Histone H2A | Histone H2B | Histone H3 | Histone Lysine Demethylase | Histone methyltransferase | HIVEP1 | HIVEP2 | HIVEP3 | HJURP | HJV | HK1 | HK2 | HK2P1 | HK3 | HKDC1 | HLA Class II Histocompatibility Antigen DM (HLA-DM) | HLA class II histocompatibility Antigen DO (HLA-DO) | HLA class II histocompatibility antigen DP (HLA-DP) | HLA Class II Histocompatibility Antigen DQ8 | HLA class II histocompatibility antigen DR (HLA-DR) | HLA Class II Histocompatibility Antigen, DQ (HLA-DQ) | HLA class II histocompatibility antigen, DRB1-7 beta chain, transcript variant X1 | HLA complex group 16 (non-protein coding), transcript variant X2 | HLA complex group 8 | HLA-A | HLA-B | HLA-C | HLA-DMA | HLA-DMB | HLA-DOA | HLA-DOB | HLA-DPA1 | HLA-DPA2 | HLA-DPA3 | HLA-DPB1 | HLA-DPB2 | HLA-DQA1 | HLA-DQA2 | HLA-DQB1 | HLA-DQB1-AS1 | HLA-DQB2 | HLA-DRA | HLA-DRB1 | HLA-DRB2 | HLA-DRB3 | HLA-DRB4 | HLA-DRB5 | HLA-DRB6 | HLA-DRB7 | HLA-DRB8 | HLA-DRB9 | HLA-E | HLA-F | HLA-F-AS1 | HLA-G | HLA-H | HLA-J | HLA-K | HLA-L | HLA-N | HLA-P | HLA-U | HLA-V | HLA-W | HLCS | HLF | HLTF | HLX | HM13 | HMBOX1 | HMBS | HMCES | HMCN1 | HMCN2 | HMG20A | HMG20B | HMGA1 | HMGA1P2 | HMGA1P4 | HMGA1P7 | HMGA1P8 | HMGA2 | HMGA2-AS1 | HMGB1 | HMGB1P1 | HMGB1P10 | HMGB1P19 | HMGB1P37 | HMGB1P38 | HMGB1P46 | HMGB1P5 | HMGB1P6 | HMGB2 | HMGB2P1 | HMGB3 | HMGB3P1 | HMGB3P14